Sublesional use of bevacizumab (avastin) in recurrent laryngeal papillomatosis

Authors

  • Olenka Alcas Arce Servicio de Otorrinolaringología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú
  • Mariella Pacheco García Servicio de Otorrinolaringología, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú

DOI:

https://doi.org/10.15381/anales.v77i3.12422

Keywords:

Human Papilloma Virus, Laryngeal Papillomatosis, Recurrent, Larynx, Bevacizumab, Avastin.

Abstract

Recurrent laryngeal papillomatosis is a disease caused by the human papillomavirus that causes exophytic epithelial lesions. Currently, there is no definitive treatment, existing high recurrence of lesions. One of the promising alternatives is the use of KTP laser with bevacizumab. However, in our hospitals we do not have KTP, but only cold excision. We present a case of recurrent laryngeal papillomatosis treated with intralesional injections of bevacizumab (avastin) 16.5 mg/mL as adjuvant therapy to cold excision.

Downloads

Published

2016-10-12

Issue

Vol. 77 No. 3 (2016)

Section

Casos clínicos

License

Copyright (c) 2016 Olenka Alcas Arce, Mariella Pacheco García

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Those authors who have publications with this magazine accept the following terms:

  1. Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
  2. Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
  3. Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).

How to Cite

1.
Alcas Arce O, Pacheco García M. Sublesional use of bevacizumab (avastin) in recurrent laryngeal papillomatosis. An Fac med [Internet]. 2016 Oct. 12 [cited 2024 Jul. 17];77(3):283-5. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/12422